Results 211 to 220 of about 23,609 (230)
Some of the next articles are maybe not open access.
Romiplostim-induced myelofibrosis
Blood, 2013![Figure][1] A 55-year-old woman with chronic refractory idiopathic thrombocytopenic purpura (ITP) presented with gum bleeding for 1 day. Over the course of several years, she had failed, or became resistant to, multiple treatments including glucocorticoids, intravenous immunoglobulin,
Michele R. Roullet, Armin Rashidi
openaire +3 more sources
The ABCCs of myelofibrosis [PDF]
Blood, 2005 Comment on Barosi et al, page [2849][1] “The illness which he'd been smitten should have been analyzed when caught something like spleen that scourge of Britain or Russia's chondria for short” —Alexander Pushkin Eugene Onegin (1823), stanza 38 For nearly 150 years, the ...
openaire +1 more source
American Journal of Clinical Pathology, 1982
This report describes a 20-year-old patient with rapidly fatal fibrosis of the bone marrow associated with leukopenia, anemia, and large number of myeloblasts in peripheral blood. The bone marrow revealed extensive fibrosis and hyperplasia of the myeloblasts and megakaryocytes.
openaire +2 more sources
This report describes a 20-year-old patient with rapidly fatal fibrosis of the bone marrow associated with leukopenia, anemia, and large number of myeloblasts in peripheral blood. The bone marrow revealed extensive fibrosis and hyperplasia of the myeloblasts and megakaryocytes.
openaire +2 more sources
Therapeutic approaches in myelofibrosis
Expert Opinion on Pharmacotherapy, 2011Myeloproliferative neoplasm (MPN)-associated myelofibrosis is the most disabling of the classical Philadelphia-negative MPNs. The discovery that a gain-of-function mutation of JAK2 (JAK2V617F) is present in more than 60% of patients with MPN-associated myelofibrosis has provided a new target for innovative treatment strategies.This review discusses the
G. Barosi +2 more
openaire +4 more sources
Pyoderma gangrenosum with myelofibrosis
The American Journal of Medicine, 1987Pyoderma gangrenosum is a papulovesicular skin disorder commonly associated with underlying systemic disease, but rarely with the myeloproliferative syndromes. A case of rapidly progressive pyoderma is cited in a 77-year-old white man who had no other evidence of disease aside from macrocytic anemia.
Frank J. Kroboth +2 more
openaire +3 more sources
2010
Myelofibrosis is a reactive process common to many malignant and benign disorders. Primary myelofibrosis is a chronic myeloproliferative disorder of unknown aetiology that involves a multipotent haemopoietic progenitor cell and results in abnormalities in red cell, white cell, and platelet production in association with marrow fibrosis and ...
openaire +1 more source
Myelofibrosis is a reactive process common to many malignant and benign disorders. Primary myelofibrosis is a chronic myeloproliferative disorder of unknown aetiology that involves a multipotent haemopoietic progenitor cell and results in abnormalities in red cell, white cell, and platelet production in association with marrow fibrosis and ...
openaire +1 more source
Myelofibrosis with myeloid metaplasia
Hematology/Oncology Clinics of North America, 2003MMM is a chronic myeloproliferative disorder characterized by bone marrow fibrosis and neoangiogenesis, constitutive release ofa high number of CD34+ stem cells from the bone marrow, and extramedullary hematopoiesis. It presents with heterogeneous clinical features in which anemia and progression to symptomatic splenomegaly dominate.
openaire +3 more sources